Diabetes

Journal

Publication Venue For

  • Hepatic glucagon receptor signaling enhances insulin-stimulated glucose disposal in rodents.  67:2157-2166. 2018
  • Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21.  67:1773-1782. 2018
  • Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice.  67:1867-1879. 2018
  • Genome-wide association study of serum fructosamine and glycated albumin in adults without diagnosed diabetes: Results from the atherosclerosis risk in communities study.  67:1684-1696. 2018
  • miR-204 controls glucagon-like peptide 1 receptor expression and agonist function.  67:256-264. 2018
  • Hepatic but not extrahepatic insulin clearance is lower in African American than in European American women.  66:2564-2570. 2017
  • Genetics of type 2 diabetes in U.S. Hispanic/Latino individuals: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).  66:1419-1425. 2017
  • Gestational diabetes mellitus from inactivation of prolactin receptor and MafB in islet β-cells.  65:2331-2341. 2016
  • Skeletal muscle TRIB3 mediates glucose toxicity in diabetes and high-fat diet-induced insulin resistance.  65:2380-2391. 2016
  • Loss of NOX-derived superoxide exacerbates diabetogenic CD4 T-cell effector responses in type 1 diabetes.  64:4171-4183. 2015
  • Augmented STAT5 signaling bypasses multiple impediments to lactogen-mediated proliferation in human β-cells.  64:3784-3797. 2015
  • β-cell microRNAs: Small but powerful.  64:3631-3644. 2015
  • Unsticking the broken diabetic heart: O-GlcNAcylation and calcium sensitivity.  64:3339-3341. 2015
  • Growth hormone inhibits hepatic de novo lipogenesis in adult mice.  64:3093-3103. 2015
  • Response to Comment on Sofi et al. pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence. Diabetes 2014;63:632-644.  64:e20-e21. 2015
  • Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes.  64:937-946. 2015
  • Inhibition of Ca2+-independent phospholipase A2β (iPLA2β) ameliorates islet infiltration and incidence of diabetes in NOD mice.  64:541-554. 2015
  • A31: Rare and Common Exome Variants Are Associated with Fasting Glucose and Insulin Levels-The CHARGE-S Exome Chip and Sequencing Study.  63:A37-A37. 2014
  • BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans.  63:791-800. 2014
  • Epigenome-wide association study of fasting measures of glucose, insulin, and homa-ir in the genetics of lipid lowering drugs and diet network study.  63:801-807. 2014
  • GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats.  63:505-513. 2014
  • Bilirubin: A potential biomarker and therapeutic target for diabetic nephropathy.  63:2613-2616. 2014
  • Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors.  63:122-131. 2014
  • Downregulation of carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion.  63:3805-3814. 2014
  • Effect of guanylate cyclase-C activity on energy and glucose homeostasis.  63:3798-3804. 2014
  • Islet-1 is essential for pancreatic β-cell function.  63:4206-4217. 2014
  • KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression.  63:2949-2961. 2014
  • TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway.  62:4192-4200. 2013
  • GLP-1R agonism enhances adjustable gastric banding in diet-induced obese rats.  62:3261-3267. 2013
  • A431: Epigenetics of Fasting Insulin and Glucose Concentrations.  62:A431-A431. 2013
  • Fibroblast growth factor 21 mediates specific glucagon actions.  62:1453-1463. 2013
  • Islet a-, b-, and d-Cell development is controlled by the ldb1 coregulator, acting primarily with the islet-1 transcription factor.  62:875-886. 2013
  • Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow.  62:273-282. 2013
  • Clinical islet xenotransplantation: How close are we?.  61:3046-3055. 2012
  • Caloric restriction chronically impairs metabolic programming in mice.  61:2734-2742. 2012
  • Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance.  61:2776-2786. 2012
  • Preventing β-cell loss and diabetes with calcium channel blockers.  61:848-856. 2012
  • IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response.  60:3223-3234. 2011
  • Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.  60:2624-2634. 2011
  • Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes.  60:2144-2151. 2011
  • Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance.  60:177-188. 2011
  • Redox modulation protects islets from transplant-related injury.  59:1731-1738. 2010
  • Admixture Mapping of Type 2 Diabetes and Lipoprotein Subclasses in Gullah-Speaking African Americans in Project SuGAR.  59:A337-A337. 2010
  • Changes in Insulin Sensitivity in Overweight/Obese Patients Treated with Low-Dose, Controlled-Release Phentermine/Topiramate(PHEN/TPM).  59:A481-A481. 2010
  • Diabetes and Oral Health among Rural, Ethnically Diverse Older Adults.  59:A307-A307. 2010
  • Effects of Resistance Exercise and Aging on NR4A Protein Levels in Skeletal Muscle.  59:A319-A320. 2010
  • Enhanced Rat Islet Function and Survival In Vitro Using a Biomimetic Self-Assembled Nanomatrix Gel.  59:A533-A533. 2010
  • Improvements in Dyslipidemia and Other Cardiometabolic Disease Risk Factors with Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM).  59:A290-A291. 2010
  • Initial Combination Therapy with Metformin plus Colesevelam Safely Achieves Glycemic and Lipid Goals with Less Diarrhea in Early Type 2 Diabetes Mellitus.  59:A187-A187. 2010
  • Lipid Metabolism Modulated by Macrophage Adiponectin Expression In Vivo.  59:A433-A433. 2010
  • Macrophage and T Cell ROS Production Is Critical for T1D Pathogenesis.  59:A361-A361. 2010
  • Metabolic Effects of Adipocyte-Specific NR4A3 Over-Expression in Mice.  59:A394-A394. 2010
  • Osteocalcin Effects on Cytokine Secretion by Adipose Tissue and Glucose Uptake in L6 Muscle Cells: Linking the Skeleton with Insulin Resistance and Inflammation.  59:A395-A395. 2010
  • The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus.  59:A173-A173. 2010
  • Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis.  59:791-799. 2010
  • Duration of lactation and incidence of the metabolic syndrome in women of reproductive age according to gestational diabetes mellitus status: A 20-year prospective study in CARDIA (Coronary Artery Risk Development in Young Adults).  59:495-504. 2010
  • Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated β-cell death.  59:440-447. 2010
  • HDL as a biomarker, potential therapeutic target, and therapy.  58:2711-2717. 2009
  • Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance.  58:2498-2505. 2009
  • FoxO1 links insulin resistance to proinflammatory cytokine IL-1β production in macrophages.  58:2624-2633. 2009
  • Selective inhibition of protein kinase C β2 attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.  58:2355-2364. 2009
  • Islet-1 is required for the maturation, proliferation, and survival of the endocrine pancreas.  58:2059-2069. 2009
  • Apolipoprotein-Defined Lipoproteins in the DCCT/EDIC Cohort: Associations with Diabetic Nephropathy in Type 1 Diabetes.  58:A243-A243. 2009
  • Genes and Biochemical Pathways in Human Skeletal Muscle Affecting Resting Energy Expenditure and Fuel Partitioning.  58:A362-A362. 2009
  • Inhibition of Superoxide Synthesis Prevents T Cell Autoreactivity.  58:A50-A50. 2009
  • One-Year Treatment with VI-0521 in Type 2 Diabetes Demonstrates Continued Glycemic Improvement and Weight Loss.  58:A95-A95. 2009
  • Redox Modulation Ablates Adaptive Immune Effector Response by Inhibiting IL-12-IL-12R Signaling.  58:A327-A328. 2009
  • Genome-wide linkage scan in gullah-speaking african american families with type 2 diabetes: The sea islands genetic African American Registry (Project SuGAR).  58:260-267. 2009
  • Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: Evidence for blunted responsiveness in diabetes.  57:2488-2494. 2008
  • Effect of VI-0521 (phentermine and topiramate) in type 2 diabetes.  57:A112-A112. 2008
  • Genome-wide linkage scan in Gullah-speaking African American families with Type 2 diabetes: The Sea Islands Genetic African American Registry (Project SuGAR).  57:A321-A321. 2008
  • Metabolic syndrome traits and endothelial dysfunction: Role of ethnicity.  57:A620-A620. 2008
  • Osteocalcin is not just for bones: Effects on adipocytes and role in human metabolism.  57:A29-A29. 2008
  • Overexpression of adiponectin reduces lipid accumulation in human THP-1 macrophage foam cells.  57:A631-A631. 2008
  • Reactive oxygen species generation is necessary for diabetogenic T cell effector function.  57:A354-A354. 2008
  • Redox modulation impairs allograft rejection.  57:A543-A544. 2008
  • Redox modulation regulates T cell activation and effector function through a tumor necrosis factor alpha converting enzyme (TACE) dependent mechanism.  57:A53-A53. 2008
  • The HOMA index estimation of insulin resistance is affected by ethnicity.  57:A292-A292. 2008
  • Thioredoxin-interacting protein A critical link between glucose toxicity and β-cell apoptosis.  57:938-944. 2008
  • A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: The coronary artery risk development in young adults (CARDIA) study.  56:2990-2996. 2007
  • Body size and shape changes and the risk of diabetes in the diabetes prevention program.  56:1680-1685. 2007
  • Critical role of superoxide (O2-) production in the pathogenesis of autoimmune diabetes (T1D).  56:A59-A59. 2007
  • Ethnic differences in adiponectin multimer distribution and relationships with metabolic syndrome traits.  56:A361-A361. 2007
  • Fat depots and adipokines in morbidly obese individuals.  56:A464-A464. 2007
  • Functional study of Trb 3 related to diabetic skeletal muscle.  56:A346-A346. 2007
  • Pioglitazone therapy restores the coupling of electron transport to ATP synthesis in skeletal muscle of obese zucker rats.  56:A85-A86. 2007
  • Reactive oxygen species generation is necessary for autoimmune T cell effector function.  56:A58-A59. 2007
  • Genotype-by-sex interaction on fasting insulin concentration: The HyperGEN study.  56:137-142. 2007
  • Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.  55:3455-3462. 2006
  • Polymorphism in the transcription factor 7-Like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women.  55:3630-3634. 2006
  • Suppressed insulin signaling and increased apoptosis in Cd38-null islets.  55:2737-2746. 2006
  • A diabetes management program using diabetes-specific meal replacements and snack bars improves weight loss, metabolic parameters, and quality of life (QOL).  55:A596-A596. 2006
  • A role for C/EBP-delta in mitochondrial dysfunction and insulin resistance in skeletal muscle.  55:A304-A304. 2006
  • Blockade of the inflammatory third signal in conjunction with antigenic immunization as a potentially novel immunosuppression strategy.  55:A447-A447. 2006
  • CETP gene variation has pronounced independent effect on HDL levels and HDL particle size in type 1 diabetes.  55:A252-A252. 2006
  • Effects of short-term very low calorie diet (VLCD) on secretion of adipocytokines in human adipose tissue.  55:A313-A313. 2006
  • Redox modulation inhibits diabetogenic T cell activation and T1D.  55:A89-A89. 2006
  • Resistin autoregulates inflammatory cytokine production and induces insulin resistance in adipocytes.  55:A310-A310. 2006
  • The role of ER-stress in the antigenic response of the BDC-2.5 T cell.  55:A88-A88. 2006
  • Quantitative trait loci on chromosome 8q24 for pancreatic β-cell function and 7q11 for insulin sensitivity in obese nondiabetic white and black families: Evidence from genome-wide linkage scans in the NHLBI Hypertension Genetic Epidemiology Network (HyperGEN) study.  55:551-558. 2006
  • Adiponectin multimeric complexes and the metabolic syndrome trait cluster.  55:249-259. 2006
  • Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents.  54:2772-2778. 2005
  • Adiponectin multimeric complexes and the metabolic syndrome trait cluster.  54:A347-A348. 2005
  • Administration of pioglitazone to LDL receptor-deficient mice inhibits progression of intimal lesions and expression of matrix metalloproteinases and adhesion molecules.  54:A182-A182. 2005
  • Catalytic antioxidant disruption of innate-mediated pro-inflammatory cytokine and reactive oxygen species third signal delays spontaneous autoimmune diabetes in the NOD mouse.  54:A25-A25. 2005
  • Dysregulation of mitochondria-related genes in skeletal muscle from insulin resistant humans is associated with suppression of transcription factors involved in mitochondrial biogenesis.  54:A273-A273. 2005
  • Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages.  54:A188-A188. 2005
  • Proteomics analysis of skeletal muscle mitochondria in type 2 diabetes reveals altered concentrations and oxidation of respiratory chain proteins.  54:A58-A59. 2005
  • Linkage analysis of diabetes status among hypertensive families: The hypertension genetc epidemiology network study.  53:3307-3312. 2004
  • Activated protein C preserves functional islet mass after intraportal transplantation: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death.  53:2804-2814. 2004
  • Impaired Cardiac Efficiency and Increased Fatty Acid Oxidation in Insulin-Resistant ob/ob Mouse Hearts.  53:2366-2374. 2004
  • Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting.  53:1671-1679. 2004
  • Associations of adiponectin with retinopathy in the DCCT/EDIC cohort: Influence of insulin resistance.  53:A254-A254. 2004
  • Disruption of pro-inflammatory cytokine and reactive oxygen species dependent third signal leads to antigen-specific hyporesponsiveness that is STAT-4 dependent.  53:A301-A302. 2004
  • Effects of atypical antipsychotic drugs on insulin action in adipocytes.  53:A150-A150. 2004
  • Genetic ablation of macrophage/neutrophil NADPH oxidase activity inhibits T1D development in NOD mice.  53:A26-A26. 2004
  • Overexpression of adiponectin but not resistin enhances adipocyte differentiation and insulin sensitivity.  53:A79-A79. 2004
  • Quelling oxidative stress during human islet isolation correlates with reduced NF-kappa B-dependent pro-inflammatory mediators: Implications for the development of footprint assays for transplant success.  53:A454-A454. 2004
  • Hexosamine Pathway Is Responsible for Inhibition by Diabetes of Phenylephrine-Induced Inotropy.  53:1074-1081. 2004
  • Beta-cell calcium-independent group VIA phospholipase A(2) (iPLA(2)beta): tracking iPLA(2)beta movements in response to stimulation with insulin secretagogues in INS-1 cells..  53 Suppl 1:S186-S189. 2004
  • Islet Complex Lipids: Involvement in the Actions of Group VIA Calcium-Independent Phospholipase A2 in β-Cells.  53. 2004
  • Caspase-1 Is Not Required for Type 1 Diabetes in the NOD Mouse.  53:99-104. 2004
  • Activation of Vascular Endothelial Growth Factor Receptor-1 Sustains Angiogenesis and Bcl-2 Expression Via the Phosphatidylinositol 3-Kinase Pathway in Endothelial Cells.  52:2959-2968. 2003
  • Brain Death Significantly Reduces Isolated Pancreatic Islet Yields and Functionality In Vitro and In Vivo after Transplantation in Rats.  52:2935-2942. 2003
  • Linkage Analysis of a Composite Factor for the Multiple Metabolic Syndrome: The National Heart, Lung, and Blood Institute Family Heart Study.  52:2840-2847. 2003
  • Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-β activity.  52:2144-2150. 2003
  • Alterations in skeletal muscle caveolins 1 and 3 in human insulin resistance and obesity.  52:A330-A331. 2003
  • Relationship between insulin senstivity and intramyocellular lipid during short term very low calorie diet in obese type 2 diabetics.  52:A328-A328. 2003
  • Plasma prekallikrein: A risk marker for hypertension and nephropathy in type 1 diabetes.  52:1215-1221. 2003
  • Using genetic admixture to explain racial differences in insulin-related phenotypes.  52:1047-1051. 2003
  • Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.  52:708-716. 2003
  • Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.  52:453-462. 2003
  • Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes.  51:3461-3467. 2002
  • Troglitazone antagonizes metabolic effects of glucocorticoids in humans: Effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.  51:2895-2902. 2002
  • Flotillin-1 expression in skeletal muscle is altered in insulin resistant humans.  51:A302-A302. 2002
  • Hepatic lipase gene polymorphism is a major determinant of HDL level and HDL size in men with type 1 diabetes in the DCCT/EDIC.  51:A20-A20. 2002
  • Therapeutic induction of diabetes resistance and antigen-specific hyporesponsiveness using a superoxide dismutase mimic (AEOL 10113).  51:A288-A289. 2002
  • Type 2 diabetes leads to progressive impairment of cardiac contractility.  51:A553-A553. 2002
  • A genome-wide scan for loci linked to plasma levels of glucose and HbA 1c in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study.  51:833-840. 2002
  • Longitudinal Study on Pubertal Insulin Resistance.  50:2444-2450. 2001
  • Effects of Insulin Resistance and type 2 diabetes on the nuclear magnetic resonance lipoprotein subclass profile.  50:A147-A147. 2001
  • Effects of race on the NMR lipoprotein profile and insulin resistance syndrome: Lipids and blood pressure are not influenced by insulin resistance in African Americans.  50:A306-A306. 2001
  • Postprandial glucose and insulin responses to dextrin-containing medical nutritional bars in persons with type 2 diabetes mellitus.  50:A366-A366. 2001
  • SNARE proteins (Syntaxin4, VAMP2, munc18) and skeletal muscle insulin resistance in rats and humans.  50:A270-A270. 2001
  • Erratum: Visceral fat, insulin sensitivity and upids in prepulbertal childre. (Diabetes 48: 1515-1521, 1999).  50:477. 2001
  • Visceral fat, insulin sensitivity, and lipids in prepubertal children. (vol 48, pg 1515, 1999).  50:477-477. 2001
  • Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors.  50:515-520. 2001
  • Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.  50:2641-2645. 2001
  • Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes.  50:1227-1236. 2001
  • Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis: Role of GSK3β.  50:1171-1179. 2001
  • Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Associations with retinopathy and nephropathy.  49:A269-A269. 2000
  • Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Effects of gender, HbAlc, and DCCT randomization group..  49:A267-A267. 2000
  • Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile: Effects of hyperglycemia, lipoprotein glycation, and comparison with standard lipid profile.  49:A268-A268. 2000
  • Paraoxonase genotype (192 Gln-Arg) and serum paraoxonase-arylesterase activity: Relationship with Type 1 diabetes and nephropathy.  49:A157-A157. 2000
  • Troglitazone is an effective therapeutic agent in patients with steroid-induced diabetes.  49:A129-A129. 2000
  • Cloning of a T-type Ca 2+ channel isoform in insulin-secreting cells.  49:59-64. 2000
  • Visceral fat, insulin sensitivity, and lipids in prepubertal children.  48:1515-1521. 1999
  • Hyperfibrinogenemia is associated with nephropathy in type 1 diabetes.  48:A139-A139. 1999
  • Low birth weight is associated with reduced expression of GLUT4 and carnitine palmitoyltransferase-1 in adult skeletal muscle.  48:A274-A275. 1999
  • Plasminogen activator inhibitor-1 is increased in type 1 diabetes patients with hypertension.  48:A43-A43. 1999
  • Toward rational diagnostic criteria for the insulin resistance syndrome.  48:A29-A29. 1999
  • Troglitazone prevents glucocorticoid-induced insulin resistance in humans.  48:A75-A75. 1999
  • Apolipoprotein CIII polymorphism confers altered chemical composition of triglyceride-rich lipoprotein in type 1 diabetes.  47:A32-A32. 1998
  • Insulin resistance and defective glucose-insulin coupling in ketosis-prone type 2 diabetes of African-American youth.  47:A306-A306. 1998
  • The role of uncoupling proteins in metabolic fuel partitioning and human obesity.  47:A13-A13. 1998
  • Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African- American subjects.  47:685-687. 1998
  • Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in 1 diabetes mellitus.  47:1472-1479. 1998
  • Expression of mRNAs encoding uncoupling proteins in human skeletal muscle. Effects of obesity and diabetes.  47:1935-1940. 1998
  • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.  47:1920-1927. 1998
  • Decreased insulin-stimulated Z-deoxyglucose uptake and impaired GLUT4 translocation in skeletal muscle of transgenic mice overexpressing glutamine: Fructose-6-phosphate amidotransferase..  46:259-259. 1997
  • Ketosis-prone NIDDM in African-American children..  46:262-262. 1997
  • NIDDM and obesity are associated with Protein Kinase C abnormalities in human skeletal muscle.  46:87-87. 1997
  • Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study..  46:63-69. 1997
  • Muscle rad expression and human metabolism: Potential role of the novel ras-related GTPase in energy expenditure and body composition.  46:444-450. 1997
  • Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study..  45:742-748. 1996
  • Correlation of leptin and body fat in obese, lean, and lipodystrophic humans..  45:1229-1229. 1996
  • Dual energy X-ray absorptiometry (DXA) assessment of fat mass and distribution and its association with the insulin resistance syndrome (IRS)..  45:387-387. 1996
  • Fat and muscle tissue express a common abnormality in translocation/trafficking of GLUT4/vp165 containing vesicles in NIDDM..  45:573-573. 1996
  • The metabolic significance of leptin in humans..  45:940-940. 1996
  • Epidermal growth factor induces glucose storage in transgenic 3T3-L1 adipocytes overexpressing epidermal growth factor receptors.  45:1619-1625. 1996
  • ABNORMALITIES IN GLUT-4 TRANSLOCATION AND TRAFFICKING IN SKELETAL-MUSCLE CAUSE INSULIN-RESISTANCE IN HUMANS.  44:A164-A164. 1995
  • GLUCOSAMINE (GLMN) INDUCES INSULIN-RESISTANCE (IR) IN-VIVO BY AFFECTING GLUT 4 TRANSLOCATION IN SKELETAL-MUSCLE - IMPLICATIONS FOR GLUCOSE TOXICITY.  44:A15-A15. 1995
  • RAD EXPRESSION IN SKELETAL-MUSCLE OF TYPE-II DIABETICS.  44:A186-A186. 1995
  • MUSCLE GLUT 4 EXPRESSION IS A FAMILIAL TRAIT AND DETERMINES INSULIN SENSITIVITY IN HUMANS INDEPENDENT OF OBESITY.  43:A69-A69. 1994
  • THE GOLGI-APPARATUS IS NOT REQUIRED FOR INSULIN STIMULATION OF GLUCOSE-TRANSPORT AND GLUT-4 TRANSLOCATION IN RAT ADIPOCYTES.  43:A119-A119. 1994
  • Biological actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes: Chronic ability to increase glycogen synthase activity.  43:53-62. 1994
  • Saturated fatty acid-induced insulin resistance in rat adipocytes.  43:540-545. 1994
  • Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.  42:1773-1785. 1993
  • MECHANISMS UNDERLYING PERIPHERAL-NERVE GLUCOSE-UPTAKE SUPPRESSION IN DIABETES.  42:A102-A102. 1993
  • Amplification of insulin secretion by lipid messengers.  42:367-374. 1993
  • Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.  42:1773-1785. 1993
  • Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.  41:465-475. 1992
  • Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes: Effects on glucose transporter gene expression.  41:274-285. 1992
  • Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site.  40:482-485. 1991
  • Renal adaptation to dietary phosphate restriction in rats: Interactions with insulin and calcitriol.  40:1134-1140. 1991
  • Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.  37:590-599. 1988
  • Interferon-mediated induction of Ia antigen expression on isolated murine whole islets and dispersed islet cells.  35:1174-1177. 1986
  • The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.  35:83-88. 1986
  • Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications.  35:916-921. 1986
  • Insulin induces progressive insulin resistance in cultured rat adipocytes: Sequential effects at receptor and multiple postreceptor sites.  35:258-267. 1986
  • Factors related to learning and behavior in diabetics 1985
  • The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.  34:222-234. 1985
  • Comparison of monitoring blood vs. urine glucose in obese type II diabetics 1983
  • Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in U.S. blacks.  31:532-537. 1982
  • Concordance and discrepancy in perceptions of diabetic adolescents' social behaviors: mother, father, child 1982
  • HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age forty.  31:122-125. 1982
  • Stimulation of microvascular cyclic-AMP phosphodiesterase activity by insulin, spermine and concanavalin.  31. 1982
  • Perceived needs of diabetes patient educators 1980
  • Metabolic effects of glucose insulin potassium (GIK) infusion during acute myocardial infarction (AMI).  26. 1977
  • Insulin secretion in protein-calorie malnutrition. I. Quantitative abnormalities and response to treatment..  20:542-551. 1971
  • Biochemistry of extrapancreatic tumor hypoglycemia..  19:248-258. 1970
  • Hyperglycemic, hyperosmolar, nonketoacidotic diabetes. A complication of steroid and immunosupressive therapy..  18:107-110. 1969
  • International Standard Serial Number (issn)

  • 0012-1797
  • Electronic International Standard Serial Number (eissn)

  • 0012-1797
  • 1939-327X